Publication: Multi-Center Prospective Evaluation of Discharge Criteria for Hospitalized Patients with Crimean-Congo Hemorrhagic Fever
| dc.authorscopusid | 24073322700 | |
| dc.authorscopusid | 7004406526 | |
| dc.authorscopusid | 26025098600 | |
| dc.authorscopusid | 36179346000 | |
| dc.authorscopusid | 56254216200 | |
| dc.authorscopusid | 6507180529 | |
| dc.authorscopusid | 7004280132 | |
| dc.contributor.author | Leblebicioglu, H. | |
| dc.contributor.author | Sünbül, M. | |
| dc.contributor.author | Barut, S. | |
| dc.contributor.author | Büyüktuna, S.A. | |
| dc.contributor.author | Özkurt, Z. | |
| dc.contributor.author | Yapar, D. | |
| dc.contributor.author | Yilmaz, G. | |
| dc.date.accessioned | 2020-06-21T13:32:12Z | |
| dc.date.available | 2020-06-21T13:32:12Z | |
| dc.date.issued | 2016 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Leblebicioglu] Hakan, Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Sünbül] Mustafa, Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Barut] Şener, Department of Infectious Diseases and Clinical Microbiology, Tokat Gaziosmanpaşa Üniversitesi, Tokat, Turkey; [Büyüktuna] Seyit Ali, Department of Infectious Diseases and Clinical Microbiology, Cumhuriyet Üniversitesi Tip Fakültesi, Sivas, Turkey; [Özkurt] Zülal, Department of Infectious Diseases and Clinical Microbiology, Ataturk University, Faculty of Medicine, Erzurum, Turkey; [Yapar] Derya, Department of Infectious Diseases and Clinical Microbiology, Hitit University, Corum, Corum, Turkey; [Yilmaz] Gürdal, Department of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University, Trabzon, Trabzon, Turkey; [Güner] Rahmet, Department of Infectious Diseases and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara, Turkey; [But] Ayşe Dinc, Department of Infectious Diseases and Clinical Microbiology, Ankara Numune Education and Research Hospital, Ankara, Turkey; [Çiçek-Şentürk] Gönül, Department of Infectious Diseases and Clinical Microbiology, T. C. Sağlık Bakanlığı Ankara Diskapi Yildirim Beyazit Eğitim ve Araştirma Hastanesi, Ankara, Turkey; [Murat] Naci, Department of Industrial Engineering, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Özaras] Reŝat, Department of Infectious Diseases and Clinical Microbiology, İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Istanbul, Turkey; [Bakir] Mehmet,; [Baykam] Nurcan (n),; [Bodur] Hürrem,; [Bozkurt] Ilkay,; [Köksal] Iftíhar,; [Şencan] Irfan, | en_US |
| dc.description.abstract | Introduction The information of discharge criteria in patients with Crimean-Congo Hemorrhagic Fever (CCHF) is limited. In this study, we aimed to determine the clinical and laboratory parameters used in discharging the patients by the experienced centers. Materials and methods The study was done in 9 reference centers of CCHF from May 1, 2015 to December 1, 2015 and included laboratory-confirmed patients with CCHF. The study was prospective, observational and non-interventional. Results The study included 260 patients. Mean age was 51.3 ± 16.3 years; 158 (60.8%) were male. Mean hospital stay was 7 ± 2.6 days. The decision of discharging was taken considering clinical and laboratory findings. On discharge, no patients had fever or hemorrhage. The patients were followed-up clinically and a repeat CCHF PCR was not studied. All centers considered the following criteria for discharge: no fever and hemorrhage, improvement in clinical findings and laboratory studies. For all patients except one, platelet count was >50,000/mm3 and had a tendency to increase. Prothrombin time and international normalized ratio (INR) were normal in 258 (99.6%) and 254 (98.1%) patients respectively. Alanine aminotransferase (ALT) was either normal or not higher than 10-fold and had a tendency to decrease in 259 (99.6%) patients. ALT and aspartate aminotransferase (AST) levels were not taken as discharge criteria with priority. During 30 days following the discharge, complication, relapse, or secondary transmission were not reported. Conclusions The discharging practice of the centers based on clinical and laboratory parameters seems safe considering no complications, relapses, or secondary infection thereafter. Current discharge practice of the centers composed of no fever and hemorrhage, improvement in clinical findings, platelet count of either >100,000/mm3 or >50,000/mm3 with a tendency to increase, and normal bleeding tests can be used as the criteria of discharge. © 2016 Elsevier B.V. | en_US |
| dc.identifier.doi | 10.1016/j.antiviral.2016.07.010 | |
| dc.identifier.endpage | 13 | en_US |
| dc.identifier.issn | 0166-3542 | |
| dc.identifier.issn | 1872-9096 | |
| dc.identifier.pmid | 27424492 | |
| dc.identifier.scopus | 2-s2.0-84979285124 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 9 | en_US |
| dc.identifier.uri | https://doi.org/10.1016/j.antiviral.2016.07.010 | |
| dc.identifier.volume | 133 | en_US |
| dc.identifier.wos | WOS:000384856200002 | |
| dc.identifier.wosquality | Q1 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier B.V. | en_US |
| dc.relation.ispartof | Antiviral Research | en_US |
| dc.relation.journal | Antiviral Research | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Crimean-Congo Hemorrhagic Fever | en_US |
| dc.subject | Discharge Disposition | en_US |
| dc.subject | Reported Outcomes | en_US |
| dc.title | Multi-Center Prospective Evaluation of Discharge Criteria for Hospitalized Patients with Crimean-Congo Hemorrhagic Fever | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
